Web app for reporting side effects during radiation therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective project develops and implements a secure web-based application for patients to complete standardized electronic patient-reported outcome questionnaires during and after radiotherapy. Participants will complete weekly questionnaires during treatment and at each scheduled follow-up visit for up to two years, with responses sent via HTTPS to the Institute of Oncology Ljubljana. Responses will be triaged by a traffic-light system to guide clinical actions and prioritize follow-up, aiming to support remote monitoring and optimize clinic workload. Healthcare professionals at the Institute will review submissions and use them to inform timely interventions and reduce unnecessary outpatient visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients receiving radiotherapy for gynecologic cancer, urologic cancer, or breast cancer at the Institute of Oncology Ljubljana.
* Ability to access and use the web-based application on a smartphone, computer, or tablet.
* Signed written informed consent.

Exclusion Criteria:

* Inability to understand the questionnaire questions and provide meaningful answers.

Where it's running

• Institute of Oncology Ljubljana
  Ljubljana, Slovenia Recruiting

Study contacts

• Study coordinator: Barbara Zobec Logar, MD
• Email: HLogar@onko-i.si
• Phone: +38615879273

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized supervised exercise program for adults with breast or gynecologic cancer

  A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07765927

• Blood extracellular vesicles to detect chemotherapy-related nerve damage.

  We will test whether tiny blood particles called extracellular vesicles can predict who will develop chemotherapy-induced peripheral neuropathy in adults receiving taxane, platinum, or antimitotic chemotherapy.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07558447

• High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)

  This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07524114

• Riluzole to prevent thinking and memory problems during chemotherapy

  This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07447050

• 7-day Via Shalva integrative retreat for breast and gynecologic cancer survivors

  This pilot will try a 7-day integrative retreat called Via Shalva for breast and gynecologic cancer survivors to see if the program is feasible and whether participants show changes in symptoms, wearable physiological data, and biological markers versus matched controls.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT07398079

• Guided meditation during radiation for breast and gynecologic cancers

  This project will test whether short guided meditations played during daily radiation can reduce anxiety for adults receiving radiation for breast or gynecologic cancer.

  Recruiting Phase 3 University of Utah · Salt Lake City, Utah · NCT07166042

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.